This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Asahi Kasei Pharma Corporation. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2014
Title: Shunsuke Kaneko: Innovator in Medicinal Chemistry
Introduction
Shunsuke Kaneko is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative patents. With a total of three patents to his name, Kaneko's work focuses on compounds that have therapeutic applications.
Latest Patents
One of Kaneko's latest patents is for a sulfonamide compound and its crystal form, specifically (S)-1-(4-Chloro-5-isoquinolinesulfonyl)-3-(methylamino)pyrrolidine monohydrochloride. This compound exhibits excellent properties as an active ingredient in medications for the prophylactic and therapeutic treatment of glaucoma. Another notable patent involves an 8-substituted isoquinoline derivative, which has IKKβ inhibiting activity and is useful for the prevention and treatment of IKKβ-associated diseases.
Career Highlights
Shunsuke Kaneko is currently employed at Asahi Kasei Pharma Corporation, where he continues to advance his research in medicinal chemistry. His work has garnered attention for its potential impact on healthcare and treatment options.
Collaborations
Kaneko collaborates with esteemed colleagues, including Hitoshi Kida and Koki Matsubara, to further enhance the scope and application of his inventions.
Conclusion
Shunsuke Kaneko's innovative contributions to medicinal chemistry highlight his role as a key inventor in the field. His patents reflect a commitment to developing effective treatments for serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile